For decades, Democrats and Republicans have had very different positions on drug prices. Democrats, led by Hillary Clinton portrayed drug companies—like other profitable industries—as greedy profiteers whose prices should be cut by having government ‘negotiate’ drug prices as they do in Europe, Canada and China. Indeed, Mrs. Clinton nearly wiped out the vaccine industry with her proposal to have the government purchase childhood immunizations at a government set price.
Republicans have taken a more nuanced approached. They recognized drugs have been about 12-14 percent of health care spending and that more often than not, new medicines—while expensive and risky to produce—saved lots of lives and reduced the social and economic burden of more expensive and less effective alternatives. It addressed out of pocket costs by creating a Medicare prescription drug that used market forces to keep prices down.